secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cue Biopharma, Inc. (CUE)
CIK:        0001645460
Form:       8-K
Filed at:   2024-10-08T23:59:59+00:00
Accession:  0000950170-24-113520
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cue Biopharma stockholders approve doubling authorized common stock to 200M shares
--------------------------------------------------------------------------------

- Authorized shares increased from 110M to 210M total, common from 100M to 200M.
- Shareholders voted 29,291,818 for, 7,409,258 against, 499,006 abstain at Oct 8, 2024 special meeting.
- Certificate of Amendment filed with Delaware Secretary of State on October 8, 2024.
- No specific issuance plan disclosed; amendment provides flexibility for future capital needs.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645460/000095017024113520/0000950170-24-113520-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645460/000095017024113520/cue-20241008.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-113520

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer